Foundation Medicine Appoints Gary Palmer, M.D., as Senior Vice President of Medical Affairs and Commercial Development
Foundation Medicine Appoints Gary Palmer, M.D., as Senior Vice President of Medical Affairs and Commercial Development
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., a personalized cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine clinical care, today announced the appointment of Gary Palmer, M.D., J.D., M.B.A., M.P.H. to the newly created position of senior vice president, medical affairs and commercial development. In this role, Dr. Palmer will drive …
Read more on Business Wire
Categories: Breast Cancer Information Tags: Affairs, Appoints, Commercial, Development, Foundation, Gary, M.D., Medical, medicine, Palmer, President, Senior, Vice
Key information about breast cancer risk and development is found in ‘junk’ DNA
Key information about breast cancer risk and development is found in ‘junk’ DNA
A new genetic biomarker that indicates an increased risk for developing breast cancer can be found in an individual’s “junk” (non-coding) DNA, according to a new study featuring work from researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues.
Read more on PhysOrg
Categories: Breast Cancer Mammogram Tags: About, breast, cancer, Development, Found, information, Junk, Risk
ZIOPHARM Oncology Appoints Michael G. King, Jr. as Senior Vice President of Corporate Development & Communication
ZIOPHARM Oncology Appoints Michael G. King, Jr. as Senior Vice President of Corporate Development & Communication
ZIOPHARM Oncology, Inc. announced today that it has appointed Michael G. King, Jr., Senior Vice President of Corporate Development and Communication. In this newly established position, Mr.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Risks Tags: Appoints, communication, Corporate, Development, king, Michael, Oncology, President, Senior, Vice, ZIOPHARM
Q&A: Pfizer’s Mao Mao on Using Next-Generation Sequencing in Drug Development
Q&A: Pfizer’s Mao Mao on Using Next-Generation Sequencing in Drug Development
As next-generation sequencing becomes increasingly used in disease research, pharmaceutical companies are also looking to use the technology for drug development, to identify patients for clinical trials, and to find disease biomarkers.
Read more on GenomeWeb News
Categories: Breast Cancer Tumor Tags: Development, drug, nextgeneration, Pfizer's, Sequencing, Using
Celsion Receives Fast Track Designation For ThermoDox® Development Program To Treat Primary Liver Cancer
Celsion Receives Fast Track Designation For ThermoDox® Development Program To Treat Primary Liver Cancer
Celsion Corporation (Nasdaq: CLSN ), a leading oncology drug development company, today announced that the U.S. Food and Drug Administration (FDA) has designated the HEAT Study of its investigational drug, ThermoDox®, in combination with radiofrequency ablation (RFA), as a Fast Track Development Program.
Read more on PharmaceuticalOnline
Categories: Breast Cancer Risks Tags: cancer, Celsion, Designation, Development, fast, liver, Primary, program, receives, ThermoDox®, track, treat